- Home
- ICCC vs FMY Comparison
ICCC vs FMY Comparison
Compare ICCC & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- FMY
- Stock Information
- Founded
- ICCC 1982
- FMY 2005
- Country
- ICCC United States
- FMY United States
- Employees
- ICCC N/A
- FMY N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- FMY Finance/Investors Services
- Sector
- ICCC Health Care
- FMY Finance
- Exchange
- ICCC Nasdaq
- FMY Nasdaq
- Market Cap
- ICCC 47.4M
- FMY 49.6M
- IPO Year
- ICCC 1987
- FMY N/A
- Fundamental
- Price
- ICCC $5.20
- FMY $12.06
- Analyst Decision
- ICCC
- FMY
- Analyst Count
- ICCC 0
- FMY 0
- Target Price
- ICCC N/A
- FMY N/A
- AVG Volume (30 Days)
- ICCC 22.3K
- FMY 10.1K
- Earning Date
- ICCC 05-14-2025
- FMY 01-01-0001
- Dividend Yield
- ICCC N/A
- FMY 6.98%
- EPS Growth
- ICCC N/A
- FMY N/A
- EPS
- ICCC N/A
- FMY N/A
- Revenue
- ICCC $26,493,169.00
- FMY N/A
- Revenue This Year
- ICCC N/A
- FMY N/A
- Revenue Next Year
- ICCC N/A
- FMY N/A
- P/E Ratio
- ICCC N/A
- FMY N/A
- Revenue Growth
- ICCC 51.63
- FMY N/A
- 52 Week Low
- ICCC $3.34
- FMY $10.71
- 52 Week High
- ICCC $5.82
- FMY $12.17
- Technical
- Relative Strength Index (RSI)
- ICCC 47.84
- FMY 51.12
- Support Level
- ICCC $5.01
- FMY $11.95
- Resistance Level
- ICCC $5.72
- FMY $12.11
- Average True Range (ATR)
- ICCC 0.18
- FMY 0.12
- MACD
- ICCC -0.04
- FMY 0.00
- Stochastic Oscillator
- ICCC 37.50
- FMY 50.83
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.